Metraipolis › archive › dc_bf38d81c635e

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia — Europe PMC PMID:40898981

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40898981
DOI
10.1182/blood.2025029302
License (as archived)
solo-consultazione
Archived
2026-11-07T07:14:20.572Z
SHA-256 of the archived text
c9264cbd7eea0bd0f3e51bd5152262089fe7a58f2f3e520726fae30094cba614
Stable URL of this page
https://metraipolis.com/documento/dc_bf38d81c635e

How to cite

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia — Europe PMC PMID:40898981 — Europe PMC (en), https://europepmc.org/article/MED/40898981 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf38d81c635e (Metraipolis archive dc_bf38d81c635e, sha256 c9264cbd7eea0bd0f3e51bd5152262089fe7a58f2f3e520726fae30094cba614)
BibTeX
@misc{dcbf38d81c635e,
  title = {Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia — Europe PMC PMID:40898981},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40898981},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf38d81c635e; sha256 c9264cbd7eea0bd0f3e51bd5152262089fe7a58f2f3e520726fae30094cba614},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40898981. Agents can read the archived copy with the MCP tool read_document.